Colon Cancer ED
- Detection of early colorectal cancer & precancerous lesions
0
People watching this product now!
- Sensitivity 84.45%
- Specificity 94.22%
- A blood-based test for diagnosis of colorectal cancer by detecting a combination of proprietary epigenomics DNA methylation biomarkers
- Detection of early colorectal cancer & precancerous lesions.
- Patients with a positive test result should be referred for diagnostic
- Patients with a negative test result should discuss with their doctor when they need to be tested again
- Follow-up and monitoring
- Prognostic evaluation
- Therapeutic assessment
- Male & female aged 40 and above
- Been diagnosed with type II diabetes
- A history of colorectal cancer, adenomas, other related cancers, or a relevant familial (hereditary) cancer syndrome
- Anorectal symptoms more than two weeks
- A history of benign polyps in the colon or rectum or related cancers, like (IBD), chronic ulcerative colitis (CUC), etc.
- Habits of a high-fat diet, smoking or drinking
